Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Adenocarcinoma (non-small cell lung cancer) | 90 | 14 | |
Non-small cell lung cancer | 40 | 5 | |
Squamous cell carcinoma (non-small cell lung cancer) | 33 | 6 | |
Adenosquamous carcinoma (non-small cell lung cancer) | 7 | 1 | |
Metastatic melanoma | 3 | 2 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Fatigue | 3 | |
Hyperthyroidism | 2 | |
Joint pain | 2 | |
Muscle and joint pain | 2 | |
Blurry vision | 1 | |
Chills | 1 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 4 | |
Moderate | 2 | |
Mild | 14 | |
None | 11 |